Advancing Mandatory Product Listing

CRN strongly supports the creation of a mandatory product listing (MPL) housed at FDA to provide transparency to regulators, retailers and consumers alike.

SEPTEMBER UPDATE

NEW: CRN Disappointed, but Remains Committed to Product Listing for Dietary Supplements

  • Congressional leadership with jurisdiction over the FDA user fee reauthorization process have aligned on a version of the FDA Safety and Landmark Advancements (FDASLA) Act that does not include dietary supplement Mandatory Product Listing (MPL), diagnostics, or cosmetics.
  • What's next: There is still a chance for MPL to be part of an end-of-year omnibus package. CRN will continue to work to find a legislative vehicle for MPL while advocating for the priorities our board of directors affirmed. “There is still some very strong interest in doing these other FDA-related things before the end of the session,” said CRN’s President and CEO Steve Mister, commenting in coverage from NutraIngredients-USA.

AUGUST UPDATE

  • CRN is still at the table negotiating the details of mandatory product listing (MPL) legislation, President & CEO Steve Mister assured members in an open letter to the industry, as reported by Nutrition Insight and Nutritional Outlook.

Help CRN advance efforts to enact federal legislation that would establish an MPL for dietary supplements in the U.S. market. Contact your elected officials—be heard! Find your member of Congress.


Recent publications on policy-making details:

 

JUNE 14 UPDATE: CRN Steadfast to Secure Responsible Mandatory Product Listing for Dietary Supplements

MAY 27 UPDATE: CRN Objects to Missing Protections in FDA Safety and Landmark Advancements Act


WATCH OUR MAY 2022 TOWN HALL
DOWNLOAD THE SLIDE DECK

READ THE SENATE BILL


 

LEARN MORE ABOUT MANDATORY PRODUCT LISTING FOR SUPPLEMENTS:

MAY 16: What If There Were A Registry?—Steve Mister in CRN's Supplemental blog

APRIL 29: Mandatory Product Listing: It Won’t 'Wash the Windows' Either!—Steve Mister in NutraIngredients-USA

APRIL 27: Ignore the Red Herrings: Myths & Facts about Mandatory Product Listing—Steve Mister in Nutraceuticals World

APRIL 26: Durbin, Braun introduce legislation to improve safety and ensure transparency of dietary supplement industry

Additional resources and coverage:

More: 

 

Things to Know About Mandatory Product Listing

 

Learn how the CRN-spearheaded Supplement OWL is a model for product listing.

 

Catch up on CRN's thought leadership on MPL in the articles below:

Stop the sale of bogus supplements as a cure or treatment for COVID-19 
by Julia Gustafson with Liz Richardson of The Pew Charitable Trusts in The Hill 

A Mandatory Dietary Supplement Registry: Transparency as ‘disinfectant’
by Steve Mister in RAPS Regulatory Focus

Mandatory Product Listing: Beneficial, or Burdensome?
by Steve Mister in WholeFoods Magazine

 

CRN has supported MPL for years, see this video from 2020: